by Joshua Miller | Jan 20, 2017 | Clinical, Hematology-Oncology, Infectious Diseases & Global Public Health, Regenerative Medicine, Research
Grants focus on re-purposing drugs to treat Zika infections and using anti-cancer natural killer cells — The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) has approved a pair of $2 million awards to...
by Joshua Miller | Dec 19, 2016 | Hematology-Oncology, Medical Genetics, Research
In recent years, researchers have identified specific gene mutations linked to gastrointestinal stromal tumors (GIST), which primarily occur in the stomach or small intestine, with 5,000 to 6,000 new cases per year in the United States. But 10 to 15 percent of adult...
by Joshua Miller | Dec 19, 2016 | Gastroenterology/Hepatology, Hematology-Oncology, Research
Overturning previous assumptions, study also provides new, more realistic model for liver cancer research and drug development — Some cancers are caused by loss of enzymes that should keep cell growth in check. On the flip side, some are caused by...
by Joshua Miller | Dec 16, 2016 | Hematology-Oncology, Research, Rheumatology, Allergy, & Immunology
Previous studies identified the Hippo pathway kinases LATS1/2 as a tumor suppressor, but new research led by University of California San Diego School of Medicine scientists reveals a surprising role for these enzymes in subduing cancer immunity. The findings,...
by Joshua Miller | Nov 22, 2016 | Endocrinology & Metabolism, Gastroenterology/Hepatology, Hematology-Oncology, Research, Residency Program
Researchers at University of California San Diego School of Medicine have identified a previously unknown mechanism that helps fortify the structure and tight junctions between epithelial cells — a basic cell type that lines various body cavities and organs throughout...
by Joshua Miller | Oct 28, 2016 | Hematology-Oncology, Research, Rheumatology, Allergy, & Immunology
In mouse models and patient cells, anti-CD98 antibody disrupts interactions between leukemia cells and surrounding blood vessels, inhibiting cancer’s growth — Acute myeloid leukemia (AML) is an aggressive cancer known for drug resistance and relapse. In an...
